{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:51:42Z","timestamp":1793958702908,"version":"4.8.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) often presents with insulin resistance and hormonal imbalances, metformin and probiotics are each effective treatments but the effect of combining both is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess whether the addition of probiotics to metformin treatment further improves metabolic, hormonal and gastrointestinal effects in women with PCOS. Methods: PubMed, Web of Science, Scopus, and Google Scholar were searched for English-language articles until 2 December 2025. Two reviewers screened studies, extracted data and evaluated risk of bias independently. Random effects pooled effects were calculated when possible as mean difference (MD) or standardized mean difference (SMD) with 95% confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six studies were included; compared to metformin alone the addition of probiotics decreased insulin resistance (homeostasis model assessment of insulin resistance (HOMA-IR): MD -0.50, 95% CI -0.73 to -0.26; low-to-moderate heterogeneity) and borderline significantly lowered luteinizing hormone (LH) (SMD -0.56, 95% CI -1.11 to 0.01; substantial heterogeneity), there were also fewer metformin-induced gastrointestinal adverse effects with the addition of probiotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There may be benefit to adding probiotics to metformin therapy for women with PCOS in improving insulin resistance and gastrointestinal tolerability as well as possibly decreasing LH. Heterogeneity between studies, short intervention duration and non-standardized probiotic doses\/preparations limit the strength of these findings. Further study with larger, longer, randomized controlled trials that use a standardized probiotic formulation are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251237018<\/jats:ext-link>\n                      , identifier CRD420251237018.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1802369","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:19:35Z","timestamp":1774502375000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of probiotic and metformin co-administration versus metformin monotherapy on anthropometric measurements, hormones, and glucolipid profile in women with polycystic ovary syndrome: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Mohammed","family":"Hamsho","sequence":"first","affiliation":[{"name":"Department of Nutrition and Dietetics, Faculty of Health Science, Istanbul Yeni Yuzyil University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wijdan","family":"Shkorfu","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, Faculty of Health Sciences, Bahcesehir University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Bensaoua","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, Faculty of Health Sciences, Istinye University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo Carvalho","family":"Martins","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of S\u00e3o Paulo","place":["S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hale","family":"Hac\u0131bayram","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, Faculty of Health Sciences, Bahcesehir University","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmannan","family":"Fadel","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Health, College of Medicine and Health Sciences, United Arab Emirates","place":["Al Ain, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Ranneh","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Dietetics, College of Pharmacy, Al-Ain University","place":["Abu Dhabi, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-200211000-00022","article-title":"New approach to polycystic ovary syndrome and other forms of anovulatory infertility","volume":"57","author":"Laven","year":"2002","journal-title":"Obstetrical & Gynecological Survey"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.1.5393","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.endien.2025.501578","article-title":"Therapeutic effects of chromium supplementation on women with polycystic ovarian syndrome: A systematic review and meta-analysis","volume":"72","author":"Hamsho","year":"2025","journal-title":"Endocrinol Diabetes Nutr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6754-9_13178","article-title":"Polycystic ovarian syndrome","author":"Shukla","year":"2025","journal-title":"Encycl Genet Genomics Proteomics Inf"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/nu17152436","article-title":"Effect of intermittent fasting on anthropometric measurements, metabolic profile, and hormones in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"17","author":"Ranneh","year":"2025","journal-title":"Nutrients"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2025.112524","article-title":"An endocrinological perspective on polycystic ovarian syndrome","volume":"602","author":"Basak","year":"2025","journal-title":"Mol Cell Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i7.108789","article-title":"Decoding androgen excess in polycystic ovary syndrome: Roles of insulin resistance and other key intraovarian and systemic factors","volume":"16","author":"Rambaran","year":"2025","journal-title":"World J Diabetes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06315-7","article-title":"Gut microbiota: a hidden player in polycystic ovary syndrome","volume":"23","author":"Senthilkumar","year":"2025","journal-title":"J Transl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2012.04.016","article-title":"Dysbiosis of Gut Microbiota (DOGMA) - A novel theory for the development of Polycystic Ovarian Syndrome","volume":"79","author":"Tremellen","year":"2012","journal-title":"Med Hypotheses"},{"key":"B11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2337\/dc16-1324","article-title":"Metformin is associated with higher relative abundance of mucin-degrading akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut","volume":"40","author":"De La Cuesta-Zuluaga","year":"2016","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hnm.2024.200256","article-title":"Role of gut microbiota derived short chain fatty acid metabolites in modulating female reproductive health","volume":"36","author":"Acharya","year":"2024","journal-title":"Hum Nutr Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1526109","article-title":"Metformin-mediated intestinal AMPK activation ameliorates PCOS through gut microbiota modulation and metabolic pathways","volume":"16","author":"Xu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1354-x","article-title":"Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication na\u00efve T2DM patients: a randomized clinical trial","volume":"15","author":"Sabico","year":"2017","journal-title":"J Transl Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-019-09559-0","article-title":"The effects of probiotic supplementation on clinical symptom, weight loss, glycemic control, lipid and hormonal profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a systematic review and meta-analysis of R\u2026","volume":"14","author":"Tabrizi","year":"2022","journal-title":"Probiotics Antimicrob Proteins"},{"key":"B17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.pharmthera.2024.108785","article-title":"Probiotic supplement for the treatment of polycystic ovarian syndrome","volume":"30","author":"Ramzan","year":"2025","journal-title":"Pharmacol Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for\u00a0systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B22","unstructured":"Higgins\n              JPT\n            \n            \n              Thomas\n              J\n            \n            \n              Chandler\n              J\n            \n            \n              Cumpston\n              M\n            \n            \n              Li\n              T\n            \n            \n              Page\n              MJ\n            \n          \n          London, UK: Cochrane\n          Cochrane handbook for systematic reviews of interventions\n          \n          2024"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/jpri\/2019\/v30i430275","article-title":"Effectiveness of probiotics, metformin and their combination therapy in ameliorating dyslipidemia associated with PCOS","volume":"14","author":"Zafar","year":"2019","journal-title":"J Pharm Res Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2022.2119219","article-title":"Effect of probiotics combined with metformin on improvement of menstrual and metabolic patterns in women with polycystic ovary syndrome: a randomized clinical trial","volume":"38","author":"Ji","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2025.107061","article-title":"Probiotic Lactobacillus acidophilus JYLA-126 improves metabolic outcomes in polycystic ovary syndrome: a randomized controlled trial","volume":"134","author":"Kuang","year":"2025","journal-title":"J Funct Foods"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20252716","article-title":"Effect of probiotic and metformin combination therapy on insulin resistance in polycystic ovary syndrome compared with metformin alone","volume":"14","author":"Jahan","year":"2025","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2025.2504980","article-title":"The impact of combined use of probiotics and metformin on metabolic parameters in patients with polycystic ovary syndrome","volume":"41","author":"Li","year":"2025","journal-title":"Gynecological Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.12669\/pjms.41.3.10554","article-title":"Efficacy of probiotics combined with metformin and a calorie-restricted diet in obese patients with polycystic ovary syndrome","volume":"41","author":"Luo","year":"2025","journal-title":"Pak J Med Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202505.1501.v1","article-title":"Recognizing the role of insulin resistance in polycystic ovary syndrome: A paradigm shift from a glucose-centric approach to an insulin-centric model","author":"Parker","year":"2025"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2021.313","article-title":"Influence of Insulin on LH, Testosterone and SHBG in various PCOS Categories based on the Mode of Secretion of LH in relation to FSH Levels","volume":"17","author":"Malini","year":"2021","journal-title":"Acta Endocrinol (Bucharest)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2337\/cd18-0063","article-title":"Practical insights into improving adherence to metformin therapy in patients with type 2 diabetes","volume":"37","author":"Christofides","year":"2019","journal-title":"Clin Diabetes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1529703","article-title":"Unraveling the gut microbiota\u2019s role in PCOS: a new frontier in metabolic health","volume":"16","author":"Li","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110806","article-title":"Effects of combined treatment of probiotics and metformin in management of type 2 diabetes: A systematic review and meta-analysis","volume":"202","author":"Memon","year":"2023","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1802369\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:19:37Z","timestamp":1774502377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1802369\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":33,"alternative-id":["10.3389\/fendo.2026.1802369"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1802369","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"article-number":"1802369"}}